Compare ARK Genomic Revolution ETF (ARKG) vs Lululemon Athletica Inc (LULU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Lululemon Athletica Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Lululemon Athletica Inc trades at $119.5 (market cap $13.54B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Lululemon Athletica Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | LULU | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $236.51 |
52-Week Low | $23.09 | $105.43 |
Market Cap | — | $13.54B |
Enterprise Value | — | $14.16B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Lululemon (LULU) trades at $119.26, up 2.36% on the day, showing resilience amid a challenging year where the stock has declined significantly from its highs. The technical picture is neutral with mixed signals from moving averages and oscillators, while fundamentals remain strong with consistent earnings beats, a P/E of 9.66, and robust profitability margins. Recent news highlights board stability after a proxy settlement but also ongoing consumer lawsuits and brand controversies.
The outlook is cautiously optimistic; valuation appears attractive relative to historical levels, and international growth provides upside potential. However, risks include North American market weakness, intense competition, and brand reputation concerns. Analyst consensus leans hold with a $130.53 price target, suggesting moderate upside if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Lululemon Athletica Inc
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →
